Kelly E. Seaton

3.7k total citations
29 papers, 566 citations indexed

About

Kelly E. Seaton is a scholar working on Virology, Infectious Diseases and Immunology. According to data from OpenAlex, Kelly E. Seaton has authored 29 papers receiving a total of 566 indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Virology, 13 papers in Infectious Diseases and 9 papers in Immunology. Recurrent topics in Kelly E. Seaton's work include HIV Research and Treatment (24 papers), HIV/AIDS drug development and treatment (7 papers) and HIV/AIDS Research and Interventions (6 papers). Kelly E. Seaton is often cited by papers focused on HIV Research and Treatment (24 papers), HIV/AIDS drug development and treatment (7 papers) and HIV/AIDS Research and Interventions (6 papers). Kelly E. Seaton collaborates with scholars based in United States, United Kingdom and South Africa. Kelly E. Seaton's co-authors include Georgia D. Tomaras, M. Anthony Moody, Nicole L. Yates, Charles D. Smith, S. Munir Alam, Michael R. Betts, James J. Knox, Barton F. Haynes, S. Moses Dennison and Susan Moir and has published in prestigious journals such as The Journal of Experimental Medicine, SHILAP Revista de lepidopterología and The Journal of Immunology.

In The Last Decade

Kelly E. Seaton

27 papers receiving 557 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kelly E. Seaton United States 15 263 219 170 137 86 29 566
Juan C. Bandrés United States 17 323 1.2× 453 2.1× 272 1.6× 141 1.0× 138 1.6× 28 845
Bettina Gröschel United States 11 140 0.5× 180 0.8× 228 1.3× 203 1.5× 85 1.0× 26 523
Gaby Haas Germany 12 297 1.1× 167 0.8× 115 0.7× 232 1.7× 81 0.9× 13 577
Saheli Sadanand United States 9 477 1.8× 52 0.2× 95 0.6× 248 1.8× 100 1.2× 17 775
Anthony L. Desbien United States 15 470 1.8× 115 0.5× 194 1.1× 216 1.6× 166 1.9× 20 738
Patrick Hong United States 12 337 1.3× 218 1.0× 171 1.0× 303 2.2× 247 2.9× 17 832
S. A. Jeffs United Kingdom 15 214 0.8× 246 1.1× 97 0.6× 253 1.8× 96 1.1× 33 645
Barry Walker United Kingdom 15 446 1.7× 397 1.8× 418 2.5× 218 1.6× 347 4.0× 25 912
D W Lineberger United States 9 199 0.8× 268 1.2× 245 1.4× 224 1.6× 166 1.9× 10 684
Brian Cameron United Kingdom 8 340 1.3× 55 0.3× 181 1.1× 224 1.6× 72 0.8× 10 652

Countries citing papers authored by Kelly E. Seaton

Since Specialization
Citations

This map shows the geographic impact of Kelly E. Seaton's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kelly E. Seaton with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kelly E. Seaton more than expected).

Fields of papers citing papers by Kelly E. Seaton

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kelly E. Seaton. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kelly E. Seaton. The network helps show where Kelly E. Seaton may publish in the future.

Co-authorship network of co-authors of Kelly E. Seaton

This figure shows the co-authorship network connecting the top 25 collaborators of Kelly E. Seaton. A scholar is included among the top collaborators of Kelly E. Seaton based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kelly E. Seaton. Kelly E. Seaton is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Espy, Nicole, Xue Han, Shannon Grant, et al.. (2023). Cross-protocol assessment of induction and durability of VISP/R in HIV preventive vaccine trial participants. SHILAP Revista de lepidopterología. 3(6). e0002037–e0002037. 2 indexed citations
2.
3.
Tomić, Adriana, Levi Waldron, Ludwig Geistlinger, et al.. (2021). SIMON: Open-Source Knowledge Discovery Platform. Patterns. 2(1). 100178–100178. 6 indexed citations
4.
Seaton, Kelly E., Sheetal Sawant, Jonathan Hare, et al.. (2021). Validation of a Triplex Pharmacokinetic Assay for Simultaneous Quantitation of HIV-1 Broadly Neutralizing Antibodies PGT121, PGDM1400, and VRC07-523-LS. Frontiers in Immunology. 12. 709994–709994. 6 indexed citations
5.
Seaton, Kelly E., Rachel L. Spreng, Sheetij Dutta, et al.. (2021). Subclass and avidity of circumsporozoite protein specific antibodies associate with protection status against malaria infection. npj Vaccines. 6(1). 110–110. 13 indexed citations
6.
Jin, Celina, Jennifer Hill, Bronwyn M. Gunn, et al.. (2020). Vi-specific serological correlates of protection for typhoid fever. The Journal of Experimental Medicine. 218(2). 45 indexed citations
7.
Meeren, Olivier Van Der, Erik Jongert, Kelly E. Seaton, et al.. (2020). Persistence of vaccine-elicited immune response up to 14 years post-HIV gp120-NefTat/AS01B vaccination. Vaccine. 38(7). 1678–1689. 3 indexed citations
8.
Seaton, Kelly E., Michael S. Piepenbrink, John Hural, et al.. (2020). Impact of vaccine type on HIV-1 vaccine elicited antibody durability and B cell gene signature. Scientific Reports. 10(1). 13031–13031. 6 indexed citations
9.
Jin, Celina, Rachel L. Spreng, Kelly E. Seaton, et al.. (2019). IgA and IgG1 Specific to Vi Polysaccharide of Salmonella Typhi Correlate With Protection Status in a Typhoid Fever Controlled Human Infection Model. Frontiers in Immunology. 10. 2582–2582. 32 indexed citations
10.
Kerwin, Bruce A., Rutilio H. Clark, James Floyd, et al.. (2019). Framework Mutations of the 10-1074 bnAb Increase Conformational Stability, Manufacturability, and Stability While Preserving Full Neutralization Activity. Journal of Pharmaceutical Sciences. 109(1). 233–246. 11 indexed citations
11.
Huang, Yunda, Shelly Karuna, Lindsay N. Carpp, et al.. (2018). Modeling cumulative overall prevention efficacy for the VRC01 phase 2b efficacy trials. Human Vaccines & Immunotherapeutics. 14(9). 2116–2127. 17 indexed citations
12.
Huang, Yunda, Lily Zhang, Julie E. Ledgerwood, et al.. (2017). Population pharmacokinetics analysis of VRC01, an HIV-1 broadly neutralizing monoclonal antibody, in healthy adults. mAbs. 9(5). 792–800. 26 indexed citations
13.
Knox, James J., Marcus Buggert, Lela Kardava, et al.. (2017). T-bet+ B cells are induced by human viral infections and dominate the HIV gp140 response. JCI Insight. 2(8). 114 indexed citations
14.
15.
Andersson, Anne‐Marie, Emeline Ragonnaud, Kelly E. Seaton, et al.. (2016). Effect of HIV-1 envelope cytoplasmic tail on adenovirus primed virus encoded virus-like particle immunizations. Vaccine. 34(44). 5344–5351. 11 indexed citations
16.
Abdulhaqq, Shaheed, C. Zorrilla, Guolian Kang, et al.. (2015). HIV-1-negative female sex workers sustain high cervical IFNɛ, low immune activation, and low expression of HIV-1-required host genes. Mucosal Immunology. 9(4). 1027–1038. 21 indexed citations
17.
Tomescu, Costin, Kelly E. Seaton, Peter Smith, et al.. (2014). Innate Activation of MDC and NK Cells in High-Risk HIV-1–Exposed Seronegative IV-Drug Users Who Share Needles When Compared With Low-Risk Nonsharing IV-Drug User Controls. JAIDS Journal of Acquired Immune Deficiency Syndromes. 68(3). 264–273. 17 indexed citations
18.
19.
20.
Yates, Nicole L., Judith T. Lucas, Tracy L. Nolen, et al.. (2011). Multiple HIV-1-specific IgG3 responses decline during acute HIV-1. AIDS. 25(17). 2089–2097. 66 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Juan C. Bandrés Breakdown of academic impact, for papers by Bettina Gröschel Breakdown of academic impact, for papers by Gaby Haas Breakdown of academic impact, for papers by Saheli Sadanand Breakdown of academic impact, for papers by Anthony L. Desbien Breakdown of academic impact, for papers by Patrick Hong Breakdown of academic impact, for papers by S. A. Jeffs Breakdown of academic impact, for papers by Barry Walker Breakdown of academic impact, for papers by D W Lineberger Breakdown of academic impact, for papers by Brian Cameron
Rankless by CCL
2026